参考文献/References:
[1] Lu JHolmgren A.The thioredoxin antioxidant system[J].Free Radic Biol Med,2014,66:75-87.
[2] Montezano AC,Dulak-Lis M,Tsiropoulou S,et al.Oxidative stress and human hypertension:vascular mechanisms,biomarkers,and novel therapies[J].Can J Cardiol,2015,31(5):631-641.
[3] Miwa K,Kishimoto C,Nakamura H,et al.Serum thioredoxin and alpha-tocopherol concentrations in patients with major risk factors[J].Circ J.2005.69(3):291-294.
[4] Mansego ML,Blesa S,Gonzalez-Albert V,et al.Discordant response of glutathione and thioredoxin systems in human hypertension[J].Antioxid Redox Signal,2007,9(4):507-514.
[5] Das KC,Kundumani-Sridharan V,Subramani J.Role of thioredoxin in age-related hypertension[J].Curr Hypertens Rep,2018,20(1):6.
[6] Matsuzawa A.Thioredoxin and redox signaling:roles of the thioredoxin system in control of cell fate[J].Arch Biochem Biophys,2017,617:101-105.
[7] Netto LE,Antunes F.The roles of peroxiredoxin and thioredoxin in hydrogen peroxide sensing and in signal transduction[J].Mol Cells,2016,39(1):65-71.
[8] Ren X,Zou L,Zhang X,et al.Redox signaling mediated by thioredoxin and glutathione systems in the central nervous system[J].Antioxid Redox Signal,2017,27(13):989-1010.
[9] Kundumani-Sridharan V,Subramani J,Das KC.Thioredoxin activates MKK4-NFκB pathway in a redox-dependent manner to control manganese superoxide dismutase gene expression in endothelial cells[J].J Biol Chem,2015,290(28):17505-17519.
[10] Tanito M,Nakamura H,Kwon YW,et al.Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats[J].Antioxid Redox Signal,2004,6(1):89-97.
[11] Yamagata K,Tagami M,Ikeda K,et al.Altered gene expressions during hypoxia and reoxygenation in cortical neurons isolated from stroke-prone spontaneously hypertensive rats[J].Neurosci Lett,2000,284(3):131-134.
[12] Hilgers RH,Kundumani-Sridharan V,Subramani J,et al.Thioredoxin reverses age-related hypertension by chronically improving vascular redox and restoring eNOS function[J].Sci Transl Med,2017,9(376):eaaf6094.
[13] Choi H,Allahdadi KJ,Tostes RC,Webb RC.Augmented S-nitrosylation contributes to impaired relaxation in angiotensin Ⅱ hypertensive mouse aorta:role of thioredoxin reductase[J].J Hypertens,2011,29(12):2359-2368.
[14] Park YS,Fujiwara N,Koh YH,et al.Induction of thioredoxin reductase gene expression by peroxynitrite in human umbilical vein endothelial cells[J].Biol Chem,2002,383(3-4):683-691.
[15] Mohamed IN,Hafez SS,Fairaq A,et al.Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet[J].Diabetologia,2014,57(2):413-423.
[16] Mansego ML,Solar Gde M,Alonso MP,et al.Polymorphisms of antioxidant enzymes,blood pressure and risk of hypertension[J].J Hypertens,2011,29(3):492-500.
[17] Widder JD,Fraccarollo D,Galuppo P,et al.Attenuation of angiotensinⅡ-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2[J].Hypertension,2009,54(2):338-344.
[18] Subramani J,Kundumani-Sridharan V,Hilgers RH,et al.Thioredoxin uses a GSH-independent route to deglutathionylate endothelial nitric-oxide synthase and protect against myocardial infarction[J].J Biol Chem,2016,291(45):23374-23389.
[19] Huang C,Alapa M,Shu P,et al.Guanylyl cyclase sensitivity to nitric oxide is protected by a thiol oxidation-driven interaction with thioredoxin-1[J].J Biol Chem,2017,292(35):14362-14370.
[20] Tinkov AA,Bj?rklund G,Skalny AV,et al.The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome:towards a possible prognostic marker[J].Cell Mol Life Sci,2018,75(9):1567-1586.
[21] Liu Y,Min W.Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner[J].Circ Res,2002,90(12):1259-1266.
[22] El Hadri K,Mahmood DF,Couchie D,et al.Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis[J].Arterioscler Thromb Vasc Biol,2012,32(6):1445-1452.
[23] Dagnell M,Frijhoff J,Pader I,et al.Selective activation of oxidized PTP1B by the thioredoxin system modulates PDGF-β receptor tyrosine kinase signaling[J].Proc Natl Acad Sci U S A,2013,110(33):13398-13403.
[24] Choi H,Tostes RC,Webb RC.Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and s-nitrosylation in mouse aorta[J].J Cardiovasc Pharmacol,2011,58(5):522-527.
[25] Xu S,He Y,Vokurkova M,et al.Endothelial cells negatively modulate reactive oxygen species generation in vascular smooth muscle cells:role of thioredoxin[J].Hypertension,2009,54(2):427-433.
[26] Trigona WL,Mullarky IK,Cao Y,et al.Thioredoxin reductase regulates the induction of haem oxygenase-1 expression in aortic endothelial cells[J].Biochem J,2006,394(Pt 1):207-216.
[27] Yamamoto M,Yang G,Hong C,et al.Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy[J].J Clin Invest,2003,112(9):1395-1406.
[28] Su H,Pistolozzi M,Shi X,et al.Alterations in NO/ROS ratio and expression of Trx1 and Prdx2 in isoproterenol-induced cardiac hypertrophy[J].Acta Biochim Biophys Sin (Shanghai),2017,49(11):1022-1028.
[29] Hu C,Zhang H,Qiao Z,et al.Loss of thioredoxin 2 alters mitochondrial respiratory function and induces cardiomyocyte hypertrophy[J].Exp Cell Res,2018,372(1):61-72.
[30] Yang Y,Ago T,Zhai P,et al.Thioredoxin 1 negatively regulates angiotensin Ⅱ-induced cardiac hypertrophy through upregulation of miR-98/let-7[J].Circ Res,2011,108(3):305-313.
[31] Adluri RS,Thirunavukkarasu M,Zhan L,et al.Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction:a study using thioredoxin 1 transgenic mice[J].J Mol Cell Cardiol,2011,50(1):239-247.
[32] Zhang H,Liu Q,Lin JL,et al.Recombinant human thioredoxin-1 protects macrophages from oxidized low-density lipoprotein-induced foam cell formation and cell apoptosis[J].Biomol Ther (Seoul),2018,26(2):121-129.
[33] Canesi F,Mateo V,Couchie D,et al.A thioredoxin-mimetic peptide exerts potent anti-inflammatory,antioxidant,and atheroprotective effects in ApoE2.Ki mice fed high fat diet[J].Cardiovasc Res,2019,115(2):292-301.
[34] Yu T,Zhang W,Lin Y,et al.Prognostic value of serum thioredoxin levels in ischemic stroke[J].Neurol Res,2017,39(11):988-995.
[35] Wang B,Tian S,Wang J,et al.Intraperitoneal administration of thioredoxin decreases brain damage from ischemic stroke[J].Brain Res,2015,1615:89-97.
[36] Kaya B,Erdi F,K?l?nc I,et al.Alterations of the thioredoxin system during subarachnoid hemorrhage-induced cerebral vasospasm[J].Acta Neurochir (Wien),2015,157(5):793-799;discussion 799-800.
[37] Ratliff BB,Abdulmahdi W,Pawar R,et al.Oxidant mechanisms in renal injury and disease[J].Antioxid Redox Signal,2016,25(3):119-146.
[38] Sinha N,Dabla PK.Oxidative stress and antioxidants in hypertension-a current review[J].Curr Hypertens Rev,2015,11(2):132-142.
[39] Ahmad KA,Yuan Yuan D,Nawaz W,et al.Antioxidant therapy for management of oxidative stress induced hypertension[J].Free Radic Res,2017,51(4):428-438.
相似文献/References:
[1]季春影 张瑞英.心力衰竭与心肌线粒体代谢[J].心血管病学进展,2020,(1):63.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.017]
JI ChunyingZHANG Ruiying.Heart Failure and Myocardial Mitochondrial Metabolism[J].Advances in Cardiovascular Diseases,2020,(10):63.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.017]
[2]位晨晨,钟明.糖尿病心肌病的发病机制[J].心血管病学进展,2020,(2):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
WEI Chenchen,ZHONG Ming.Pathogenesis of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(10):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
[3]严宁,杨春霞,马娟,等.β-谷甾醇对大鼠心肌缺血再灌注损伤和ERK1/2信号通路的影响[J].心血管病学进展,2020,(3):321.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.026]
YAN Ning,YANG Chunxia,MA Juan,et al.Effects of -sitosterolon Myocardial Ischemia-reperfusion Injury and ERK1/2 Signaling Pathway in Rats[J].Advances in Cardiovascular Diseases,2020,(10):321.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.026]
[4]刘家汝 关秀茹.Nrf2/ARE信号通路在动脉粥样硬化中的研究新进展[J].心血管病学进展,2020,(8):859.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.019]
LIU Jiaru,GUAN Xiuru.Nrf2/ARE Signaling Pathway in Atherosclerosis[J].Advances in Cardiovascular Diseases,2020,(10):859.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.019]
[5]李丹 徐蔓 唐其柱.Nox5在心血管疾病中的作用[J].心血管病学进展,2020,(12):1302.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.019]
Li Dan,Xu Man,Tang Qizhu.The Role of Nox5 in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(10):1302.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.019]
[6]李海通 闫莉.甲状腺疾病相关肺动脉高压发病机制研究进展[J].心血管病学进展,2021,(3):232.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.010]
LI Haitong,YAN Li.Pathogenesis of Thyroid Disease-related Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2021,(10):232.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.010]
[7]马淑青 唐其柱.氧化应激在脓毒症心肌病中的研究进展[J].心血管病学进展,2021,(2):118.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.006]
MA Shuqing,TANG Qizhu.Role of Oxidative Stress in Septic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2021,(10):118.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.006]
[8]王晓琪 苏冠华.高尿酸血症和心力衰竭的病理生理机制、治疗和预后价值[J].心血管病学进展,2021,(9):780.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
WANG Xiaoqi,SU Guanhua.Pathophysiological Mechanism, Treatment and Prognostic Value of Hyperuricemia and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(10):780.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
[9]宋雨 李耘 马丽娜.老年人衰弱和射血分数保留性心力衰竭病理生理学机制的研究进展[J].心血管病学进展,2022,(1):38.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.010]
SONG Yu,LI Yun,MA Lina.Pathophysiological Mechanisms of Frailty and Heart Failure with Preserved Ejection Fraction in the Elderly[J].Advances in Cardiovascular Diseases,2022,(10):38.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.010]
[10]周慧鑫 谌虎 刘志豪 周雨扬 李泽衍 许骁 陈华强 刘承哲 刘旨浩 王宇虹 王悦怡 赖燕秋 余锂镭 江洪.二甲双胍对心肌梗死后心脏功能的影响及其机制研究[J].心血管病学进展,2022,(3):265.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]